-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 UiWFpJx5wjhk2/UFVq0qyLGbY7aSnUsydHq8qoXKx0nc+sUdAF8NMZo4y03xxg60
 u4EnJCIRA08uEz+SLHbA3g==

<SEC-DOCUMENT>9999999997-02-037655.txt : 20020702
<SEC-HEADER>9999999997-02-037655.hdr.sgml : 20020702
<ACCEPTANCE-DATETIME>20020702155704
<PAPER>
ACCESSION NUMBER:		9999999997-02-037655
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20011231
FILED AS OF DATE:		20020701

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SYNSORB BIOTECH INC
		CENTRAL INDEX KEY:			0001025863
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-29224
		FILM NUMBER:		02040494

	BUSINESS ADDRESS:	
		STREET 1:		STE 410
		STREET 2:		1167 KENINGTON CRESCENT NW
		CITY:			CALGARY ALBERTA CANA
		STATE:			A0
		ZIP:			T2N 1X7
		BUSINESS PHONE:		4032835900
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>9999999997-02-037655.paper
<DESCRIPTION>AUTO-GENERATED PAPER DOCUMENT
<TEXT>
This document was generated as part of a paper submission.
Please reference the Document Control Number 02040494 for access to the original document.
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----